5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices.
Bone resorption requires cooperation between osteoclasts and mononuclear accessory cells by mechanisms which have not been elucidated. Since multinucleated cells in giant cell tumors of bone have many phenotypic and functional characteristics of normal osteoclasts, we have examined the interaction between the bone-resorbing multinucleated cells and the distinct mononuclear stromal cells from these tumors. We have found that these mononuclear cells produce an activity which stimulates both giant cells from giant cell tumors and rodent osteoclasts to resorb bone in vitro. We have identified the activity and found that it represents several products of the 5-lipoxygenase pathway of arachidonic acid metabolism, namely 5-hydroxyeicosatetraenoic acid and the leukotrienes. These data indicate that 5-lipoxygenase metabolites stimulate isolated osteoclasts to resorb bone in vitro and may represent a mechanism by which mononuclear stromal cells in human giant cell tumors communicate with the giant cells. In addition, these results may explain a possible mechanism for communication between accessory cells and osteoclasts involved in normal bone resorption.
Gallwitz
W E
WE
University of Texas Health Science Center, San Antonio 78284-7877.
Mundy
G R
GR
Lee
C H
CH
Qiao
M
M
Roodman
G D
GD
Raftery
M
M
Gaskell
S J
SJ
Bonewald
L F
LF
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism*; D001095:Arachidonic Acids / Q000378:metabolism / Q000494:pharmacology*; D001857:Bone Matrix / Q000502:physiology*; D001862:Bone Resorption; D002645:Chickens; D017077:Culture Media, Conditioned; D010450:Endopeptidases / Q000378:metabolism; D005260:Female; D005480:Flurbiprofen / Q000494:pharmacology; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000494:pharmacology; D007213:Indomethacin; D015289:Leukotrienes / Q000494:pharmacology*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D009637:Masoprocol / Q000494:pharmacology; D010010:Osteoclasts / Q000187:drug effects / Q000502:physiology*; D013644:Tartrates / Q000494:pharmacology; D014466:Ultraviolet Rays
D001095:Arachidonic Acids; D017077:Culture Media, Conditioned; D006893:Hydroxyeicosatetraenoic Acids; D015289:Leukotrienes; D016859:Lipoxygenase Inhibitors; D013644:Tartrates; C022022:5-hydroxy-6,8,11,14-eicosatetraenoic acid; D005480:Flurbiprofen; D009637:Masoprocol; D001094:Arachidonate 5-Lipoxygenase; D000135:Acid Phosphatase; D010450:Endopeptidases; D007213:Indomethacin